CNS Protective Effect of Selpercatinib in First-Line RET Fusion-Positive Advanced Non-Small Cell Lung Cancer.
Pérol M, Solomon BJ, Goto K, Park K, Nadal E, Bria E, Martin C, Bar J, Williams JN, Puri T, Li J, Uh MK, Lin BK, Zhou C.
Pérol M, et al. Among authors: zhou c.
J Clin Oncol. 2024 Jun 3:JCO2400724. doi: 10.1200/JCO.24.00724. Online ahead of print.
J Clin Oncol. 2024.
PMID: 38828957